A previous prospective study found the contribution of geneticvariants in hypothalamic-pituitary-adrenal (HPA) axis genes including CRHR1 to therisk of developing breast cancer (Nan et al.,2015), which was consistent with our result. This evidence concerns the gene CRHR1 and breast cancer.